Stericycle (NASDAQ: SRCL) is one of 20 publicly-traded companies in the “Waste Management, Disposal & Recycling Services” industry, but how does it contrast to its competitors? We will compare Stericycle to related businesses based on the strength of its profitability, analyst recommendations, valuation, risk, earnings, institutional ownership and dividends.
This is a breakdown of recent recommendations and price targets for Stericycle and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Stericycle currently has a consensus target price of $75.90, indicating a potential upside of 21.09%. As a group, “Waste Management, Disposal & Recycling Services” companies have a potential upside of 9.52%. Given Stericycle’s higher probable upside, equities research analysts plainly believe Stericycle is more favorable than its competitors.
Volatility & Risk
Stericycle has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500. Comparatively, Stericycle’s competitors have a beta of 0.64, meaning that their average stock price is 36% less volatile than the S&P 500.
This table compares Stericycle and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional & Insider Ownership
94.2% of Stericycle shares are held by institutional investors. Comparatively, 52.5% of shares of all “Waste Management, Disposal & Recycling Services” companies are held by institutional investors. 3.3% of Stericycle shares are held by insiders. Comparatively, 12.3% of shares of all “Waste Management, Disposal & Recycling Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Stericycle and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Stericycle||$3.56 billion||$206.35 million||-109.96|
|Stericycle Competitors||$850.65 million||$28.04 million||-368.75|
Stericycle has higher revenue and earnings than its competitors. Stericycle is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Stericycle beats its competitors on 8 of the 13 factors compared.
Stericycle Company Profile
Stericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.